Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada

Hasina Samji, Angela Cescon, Robert S. Hogg, Sharada P. Modur, Keri N. Althoff, Kate Buchacz, Ann N. Burchell, Mardge Cohen, Kelly A. Gebo, M. John Gill, Amy Justice, Gregory Kirk, Marina B. Klein, Philip (Todd) Korthuis, Jeff Martin, Sonia Napravnik, Sean B. Rourke, Timothy R. Sterling, Michael J. Silverberg, Stephen DeeksLisa P. Jacobson, Ronald J. Bosch, Mari M. Kitahata, James J. Goedert, Richard Moore, Stephen J. Gange

Research output: Contribution to journalArticle

621 Citations (Scopus)

Abstract

Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000-2007 in the U.S. and Canada. Methods: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged >20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables. Results: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts 3. Conclusions: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.

Original languageEnglish (US)
Article numbere81355
JournalPLoS One
Volume8
Issue number12
DOIs
StatePublished - Dec 18 2013

Fingerprint

Life Expectancy
Canada
History
HIV
Pharmaceutical Preparations
therapeutics
CD4 Lymphocyte Count
Mortality
drug injection
death
Therapeutics
Life Tables
risk groups
life tables
Sex Characteristics
Acquired Immunodeficiency Syndrome
Research Design
Injections
Survival
gender

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., ... Gange, S. J. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One, 8(12), [e81355]. https://doi.org/10.1371/journal.pone.0081355

Closing the gap : Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. / Samji, Hasina; Cescon, Angela; Hogg, Robert S.; Modur, Sharada P.; Althoff, Keri N.; Buchacz, Kate; Burchell, Ann N.; Cohen, Mardge; Gebo, Kelly A.; Gill, M. John; Justice, Amy; Kirk, Gregory; Klein, Marina B.; Korthuis, Philip (Todd); Martin, Jeff; Napravnik, Sonia; Rourke, Sean B.; Sterling, Timothy R.; Silverberg, Michael J.; Deeks, Stephen; Jacobson, Lisa P.; Bosch, Ronald J.; Kitahata, Mari M.; Goedert, James J.; Moore, Richard; Gange, Stephen J.

In: PLoS One, Vol. 8, No. 12, e81355, 18.12.2013.

Research output: Contribution to journalArticle

Samji, H, Cescon, A, Hogg, RS, Modur, SP, Althoff, KN, Buchacz, K, Burchell, AN, Cohen, M, Gebo, KA, Gill, MJ, Justice, A, Kirk, G, Klein, MB, Korthuis, PT, Martin, J, Napravnik, S, Rourke, SB, Sterling, TR, Silverberg, MJ, Deeks, S, Jacobson, LP, Bosch, RJ, Kitahata, MM, Goedert, JJ, Moore, R & Gange, SJ 2013, 'Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada', PLoS One, vol. 8, no. 12, e81355. https://doi.org/10.1371/journal.pone.0081355
Samji, Hasina ; Cescon, Angela ; Hogg, Robert S. ; Modur, Sharada P. ; Althoff, Keri N. ; Buchacz, Kate ; Burchell, Ann N. ; Cohen, Mardge ; Gebo, Kelly A. ; Gill, M. John ; Justice, Amy ; Kirk, Gregory ; Klein, Marina B. ; Korthuis, Philip (Todd) ; Martin, Jeff ; Napravnik, Sonia ; Rourke, Sean B. ; Sterling, Timothy R. ; Silverberg, Michael J. ; Deeks, Stephen ; Jacobson, Lisa P. ; Bosch, Ronald J. ; Kitahata, Mari M. ; Goedert, James J. ; Moore, Richard ; Gange, Stephen J. / Closing the gap : Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. In: PLoS One. 2013 ; Vol. 8, No. 12.
@article{a45daec8c20e4b2288875f02cb96ded3,
title = "Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada",
abstract = "Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000-2007 in the U.S. and Canada. Methods: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged >20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables. Results: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts 3. Conclusions: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.",
author = "Hasina Samji and Angela Cescon and Hogg, {Robert S.} and Modur, {Sharada P.} and Althoff, {Keri N.} and Kate Buchacz and Burchell, {Ann N.} and Mardge Cohen and Gebo, {Kelly A.} and Gill, {M. John} and Amy Justice and Gregory Kirk and Klein, {Marina B.} and Korthuis, {Philip (Todd)} and Jeff Martin and Sonia Napravnik and Rourke, {Sean B.} and Sterling, {Timothy R.} and Silverberg, {Michael J.} and Stephen Deeks and Jacobson, {Lisa P.} and Bosch, {Ronald J.} and Kitahata, {Mari M.} and Goedert, {James J.} and Richard Moore and Gange, {Stephen J.}",
year = "2013",
month = "12",
day = "18",
doi = "10.1371/journal.pone.0081355",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - Closing the gap

T2 - Increases in life expectancy among treated HIV-positive individuals in the United States and Canada

AU - Samji, Hasina

AU - Cescon, Angela

AU - Hogg, Robert S.

AU - Modur, Sharada P.

AU - Althoff, Keri N.

AU - Buchacz, Kate

AU - Burchell, Ann N.

AU - Cohen, Mardge

AU - Gebo, Kelly A.

AU - Gill, M. John

AU - Justice, Amy

AU - Kirk, Gregory

AU - Klein, Marina B.

AU - Korthuis, Philip (Todd)

AU - Martin, Jeff

AU - Napravnik, Sonia

AU - Rourke, Sean B.

AU - Sterling, Timothy R.

AU - Silverberg, Michael J.

AU - Deeks, Stephen

AU - Jacobson, Lisa P.

AU - Bosch, Ronald J.

AU - Kitahata, Mari M.

AU - Goedert, James J.

AU - Moore, Richard

AU - Gange, Stephen J.

PY - 2013/12/18

Y1 - 2013/12/18

N2 - Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000-2007 in the U.S. and Canada. Methods: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged >20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables. Results: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts 3. Conclusions: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.

AB - Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000-2007 in the U.S. and Canada. Methods: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged >20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables. Results: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts 3. Conclusions: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.

UR - http://www.scopus.com/inward/record.url?scp=84893164523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893164523&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0081355

DO - 10.1371/journal.pone.0081355

M3 - Article

C2 - 24367482

AN - SCOPUS:84893164523

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e81355

ER -